Artificial transposons
AssigneeThe John Hopkins University
InventorsScott E. Devine, Jef D. Boeke, Lelita T. Braiterman
Life of this patent
Estimating the term…
Abstract
We have developed efficient methods of creating artificial transposons and inserting these transposons into DNA targets in vitro, primarily for the purpose of mapping and sequencing DNA. A target DNA has been engineered to convert virtually any DNA sequence, or combination of sequences, into an artificial transposon; hence, custom transposons containing any desired feature can be easily designed and constructed. Such transposons are then efficiently inserted into DNA targets, in vitro, using the integrase activity present in yeast Ty1 virus-like particles. Primers complementary to the transposon termini can be used to sequence DNA flanking any transposon insertion.
Claims14
A kit for DNA sequencing, comprising:
- an artificial transposon having blunt-ended termini which are substrates for a retroviral or retrotransposon integrase;
- a retroviral or retrotransposon integrase;
- and
- a primer which is complementary to a terminus of said artificial transposon, wherein the transposon, the integrase and the primer are packaged in a kit.
An artificial transposon consisting of an isolated, linear, blunt-ended DNA molecule comprising:
- a marker DNA;
- a sequence of yeast retrotransposon Ty1, said sequence comprising at least 4 bp of a U3 sequence, said sequence being upstream and flanking said marker gene;
- and
- a sequence of yeast retrotransposon Ty1, said sequence comprising at least 4 bp of a U3 sequence, said sequence being downstream and flanking said marker gene, wherein each of said sequences of yeast retrotransposon Ty1 are at the termini of said linear DNA molecule.
A DNA molecule useful for generating artificial transposons, comprising:
- an origin of replication;
- a first selectable marker DNA;
- two blunt-ended transposon termini of at least 4 bp each, said termini being substrates for yeast retrotransposon Ty1 integrase, said transposon termini flanking a first restriction enzyme site useful for insertion of a second selectable marker gene to form an artificial transposon;
- a second restriction enzyme site flanking said two transposon termini, wherein digestion with said second restriction enzyme liberates a blunt-ended fragment having said transposon termini at either end of the fragment, the fragment thereby liberated being an artificial transposon.
Dependencies are inferred from the claim text.